Indeed, CD206+ macrophages often play a pro-fibrotic role in pathophysiological settings (61, 62) as opposed to the anti-fibrotic role in aHFD SAT expansion (this study) and in a model of early cardiac hypertrophy response (55). The gene discussed is MRC1; the disease is cardiac hypertrophy.